Cocrystal Pharma (COCP) vs TherapeuticsMD (TXMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
TherapeuticsMD (TXMD) has outperformed Cocrystal Pharma (COCP) over the past year, gaining 89.6% versus a loss of 14.4%. Over five years, COCP leads with a -90.5% price change compared with -94.4% for TXMD. TherapeuticsMD is the larger company by market cap ($23.3 million vs $20.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCP | TXMD |
|---|---|---|
| Share price | $1.07 | $2.01 |
| Market cap | $20.61M | $23.26M |
| 1-day change | 0.00% | +0.50% |
| YTD return | +9.18% | +23.31% |
| 1-year return | -14.40% | +89.62% |
| 5-year return | -90.51% | -94.42% |
| Forward P/E | — | 5.74 |
| EPS (TTM) | $-0.76 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.03 | $2.95 |
| 52-week low | $0.76 | $1.03 |
| Distance from 52-week high | -47.29% | -31.86% |
| Analyst consensus | none | — |
| Avg. price target upside | +741.12% | — |
| Average volume | 56.00K | 23.94K |
| Shares outstanding | 19.26M | 11.57M |
| Employees | 10 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TXMD has outperformed COCP by 104.0 percentage points over the past year.
About Cocrystal Pharma
COCP stock →Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.
Healthcare · Biotechnology · 10 employees
About TherapeuticsMD
TXMD stock →TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 1 employees
COCP vs TXMD FAQ
Which is bigger, Cocrystal Pharma or TherapeuticsMD?
TherapeuticsMD (TXMD) is larger, with a market capitalization of $23.26M compared with $20.61M for Cocrystal Pharma (COCP).
Which stock has performed better over the past year, COCP or TXMD?
TXMD returned +89.62% over the past 12 months, compared with -14.40% for COCP (price return, excluding dividends). Past performance does not predict future results.
Are Cocrystal Pharma and TherapeuticsMD in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Cocrystal Pharma and Drug Manufacturers - Specialty & Generic for TherapeuticsMD.